The following have contributed to this page: Dr Federico Cappuzzo
O-107 FISH and Immunohistochemistry (IHC) can be used to selectNSCLC patients, who will not benefit from gefitinib treatmentF. Hirsch, J. McCoy, F. Cappuzzo, W. Howard Jack, P. Gumerlock, L. Crino, W. Franklin, D. Gandara, M. Varella-Garcia, P. Bunn Jr.
- Lung Cancer, July 2005, Elsevier
- DOI: 10.1016/s0169-5002(05)80241-7